Benefits of oral Polypodium Leucotomos extract in MM high-risk patients von Aguilera, P., Carrera, C., Puig-Butille, J.A., Badenas, C., Lecha, M., González, S., Malvehy, J., Puig, S.

Volltext

Melanoma in Children, Adolescents, and Young Adults: The Spanish Cohort of the MELCAYA Consortium von Patricio da Silva-Junior, R.M., Ficapal, J., Potrony, M., Torres, T., Gil, M.E., Bague, J., Mateu, J., Crespi-Payeras, F., Podlipnik, S., Puig, J.A., Aguilera, P., Carrera, C., Alòs, L., Malvehy, J., Puig, S.

Volltext

POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families von Potrony, M., Puig‐Butille, J.A., Ribera‐Sola, M., Iyer, V., Robles‐Espinoza, C.D., Aguilera, P., Carrera, C., Malvehy, J., Badenas, C., Landi, M.T., Adams, D.J., Puig, S.

Volltext

Mutational status of naevus-associated melanomas von Shitara, D., Tell-Martí, G., Badenas, C., Enokihara, M.M.S.S., Alós, L., Larque, A.B., Michalany, N., Puig-Butille, J.A., Carrera, C., Malvehy, J., Puig, S., Bagatin, E.

Volltext

Dermoscopic criteria associated with BRAF and NRAS mutation status in primary cutaneous melanoma von Pozzobon, F.C., Puig-Butillé, J.A., González-Alvarez, T., Carrera, C., Aguilera, P., Alos, L., Badenas, C., Grichnik, J.M., Malvehy, J., Puig, S.

Volltext

Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF von Mangas, C., Potrony, M., Mainetti, C., Bianchi, E., Carrozza Merlani, P., Mancarella Eberhardt, A., Maspoli-Postizzi, E., Marazza, G., Marcollo-Pini, A., Pelloni, F., Sessa, C., Simona, B., Puig-Butillé, J.A., Badenas, C., Puig, S.

Volltext

Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population von Puig-Butillé, J.A., Carrera, C., Kumar, R., Garcia-Casado, Z., Badenas, C., Aguilera, P., Malvehy, J., Nagore, E., Puig, S.

Volltext

Discrepant mutational status between naevi and melanomas in naevus-associated melanomas: about mutation-specific immunohistochemistry: reply from the authors von Shitara, D., Tell-Martí, G., Badenas, C., Enokihara, M.M.S.S., Alós, L., Larque, A.B., Michalany, N., Puig-Butille, J.A., Carrera, C., Malvehy, J., Puig, S., Bagatin, E.

Volltext

CDKN2A mutations in melanoma families from Uruguay von Borges, A.L., Cuéllar, F., Puig-Butillé, J.A., Scarone, M., Delgado, L., Badenas, C., Milà, M., Malvehy, J., Barquet, V., Núñez, J., Laporte, M., Fernández, G., Levrero, P., Martínez-Asuaga, M., Puig, S.

Volltext

Genetic variations of patients with familial or multiple melanoma in Southern Brazil von Grazziotin, T.C., Rey, M.C.W., Bica, C.G., Pinto, L.A., Bonamigo, R.R., Puig-Butille, J.A., Cuellar, F., Puig, S.

Volltext

601 Common mechanisms and signaling pathways in fibroblasts of cancer-prone genodermatoses von Díaz, F., León, C., García-García, F., Chacón-Solano, E., Larcher, F., Carbonell, J., Puig, J.A., Puig, S., Dopazo, J., del Río, M.

Volltext

1268P Real-time clinical utility of ctDNA genomic alterations in untreated patients with advanced NSCLC von De Herreros, M. Garcia, Muñoz, S., Teixido, C., Díez-Guardia, V., Arcocha, A., Pipinikas, C., Martínez, D., Castillo, S., Reyes, R., Melia, M. Riudavets, Auclin, E., Marin, E., Howarth, K., Martinez, D., Puig, J.A., Prat, A., Aransay, N. Reguart, Viñolas, N., Mezquita, L.

Volltext

Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer‐prone genodermatoses von Chacón‐Solano, E., León, C., Díaz, F., García‐García, F., García, M., Escámez, M.J., Guerrero‐Aspizua, S., Conti, C.J., Mencía, Á., Martínez‐Santamaría, L., Llames, S., Pévida, M., Carbonell‐Caballero, J., Puig‐Butillé, J.A., Maseda, R., Puig, S., de Lucas, R., Baselga, E., Larcher, F., Dopazo, J., Río, M.

Volltext

Synchronous primary cutaneous melanomas: a descriptive study of their clinical features, histology, genetic background of the patients and clinical outcomes von Antúnez‐Lay, A., Podlipnik, S., Carrera, C., Potrony, M., Tell‐Martí, G., Badenas, C., Puig‐Butille, J.A., Espinosa, N., Puig, S., Malvehy, J.

Volltext

血液中特定 DNA 片段的水平及其与黑色素瘤分期的相关性 von Calbet‐Llopart, N., Potrony, M., Tell‐Martí, G., Carrera, C., Barreiro, A., Aguilera, P., Podlipnik, S., Puig, S., Malvehy, J., Puig‐Butillé, J.A.

Volltext

1366P - Evaluating polygenic risk score prediction model for melanoma prognosis von Potrony, M., Calbet-llopart, N., Combalia, M., Tell-Martí, G., Puig-Butille, J.A., Barreiro, A., Podlipnik, S., Carrera, C., Malvehy, J., Puig, S.

Volltext

Evaluating polygenic risk score prediction model for melanoma prognosis von Potrony, M., Calbet-llopart, N., Combalia, M., Tell-Martí, G., Puig-Butille, J.A., Barreiro, A., Podlipnik, S., Carrera, C., Malvehy, J., Puig, S.

Volltext

263P Clinical outcomes in patients with germline pathogenic variants in homologous recombination repair (HRR) genes treated with CDK4/6 inhibitors (CDK4/6i) and endocrine therapy (... von Rodriguez Hernandez, A., Martinez Saez, O., Brasó-Maristany, F., Pastor, B., Potrony, M., Moreno, L., Grau, E., Puig-Butille, J.A., Sánchez, A., Schettini, F., Conte, B., Chic, N., Vidal Losada, M.J., Munoz, M., Balaguer, F., Prat, A., Adamo, B.

Volltext

140MO HER2DX genomic test in HER2-positive/hormone receptor-positive (HER2+/HR+) breast cancer (BC) treated with neoadjuvant trastuzumab (T) and pertuzumab (P): A correlative analy... von Guarneri, V., Dieci, M.V., Griguolo, G., Pare Brunet, L., Marin, M., Miglietta, F., Bottosso, M., Giorgi, C.A., Blasco, P., Castillo, O., Galván, P., Jares, P., Puig-butille, J.A., Vivancos, A., Villagrasa Gonzalez, P., Parker, J., Perou, C.M., Conte, P.F., Prat, A.

Volltext

Detection of cell‐free circulating BRAFV600E by droplet digital polymerase chain reaction in patients with and without melanoma under dermatological surveillance von Calbet‐Llopart, N., Potrony, M., Tell‐Martí, G., Carrera, C., Barreiro, A., Aguilera, P., Podlipnik, S., Puig, S., Malvehy, J., Puig‐Butillé, J.A.

Volltext